Martin Høier Thomsen
Device Platform Manager

About

Martin Høier Thomsen is a Device Platform Manager on MGS’ Design & Development team where he plays an integral role in advancing early-phase medical device solutions from concept through realisation. He is widely recognised for his ability to translate concepts into market ready products and his commitment to sustainable, patient-centric innovation. Mr Høier Thomsen has been instrumental in the development of MGS’ new customisable autoinjector A.i.r. Platform™, drawing on his deep technical expertise and human-centred approach to guide the design from concept to functional reality.

Before joining MGS, he served as a line manager at LEO Pharma, where he built in depth knowledge of product development and what matters most to pharma innovators.

Contributions

INJECTION

ADVANCING AUTOINJECTOR PLATFORMS FOR EVOLVING DRUG AND PATIENT NEEDS

Martin Høier Thomsen introduces MGS’s A.i.r. Platform™ within the broader context of the evolution of autoinjector platforms towards more adaptable, customisable solutions. He considers how next-generation autoinjector platforms can address increasingly complex and changing demands, while helping to mitigate risk and prioritise usability.

More contributions

SUSTAINABILITY

DRIVING SUSTAINABILITY IN DRUG DELIVERY DEVICE DESIGN AND MANUFACTURING

Martin Høier Thomsen discusses the need for the pharma industry to rise to the challenges of meeting its sustainability goals, explaining how MGS’ expertise and established practices to drug delivery device design and manufacture present a forward-thinking approach to achieving this aim.